<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Organoids</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Human organoid mimics cancer-induced cachexia </title>
      <description>
        <![CDATA[The variety of organoids that can be developed in vitro is enabling major advances. Depending on the type of tissues and the research goals, these small 3D cell-based structures that mimic real tissue offer certain advantages over animal models. Scientists at the University of Padova in Italy have created human neuromuscular organoids to reproduce cancer-induced muscle cachexia, a condition that murine models do not accurately replicate.]]>
      </description>
      <guid>http://www.bioworld.com/articles/728897</guid>
      <pubDate>Tue, 17 Feb 2026 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/728897-human-organoid-mimics-cancer-induced-cachexia</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/organoids-petri-dish.webp?t=1709922088" type="image/jpeg" medium="image" fileSize="115495">
        <media:title type="plain">3D illustration of organoid models in a petri dish</media:title>
        <media:description type="plain">3D illustration of organoid models in a petri dish</media:description>
      </media:content>
    </item>
    <item>
      <title>The nose could be the key to common-cold immunity</title>
      <description>
        <![CDATA[The range of effects caused by rhinoviruses – the pathogens responsible for the common cold – motivated scientists at Yale University to study the human nasal epithelium and uncover a previously undescribed defense mechanism. The interferon-mediated protective response in these cells can limit infection, whereas a maladaptive response tends to worsen it. Based on these findings, the researchers have identified potential therapeutic targets to reduce inflammation associated with rhinovirus infection.]]>
      </description>
      <guid>http://www.bioworld.com/articles/728111</guid>
      <pubDate>Tue, 20 Jan 2026 08:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/728111-the-nose-could-be-the-key-to-common-cold-immunity</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/Sinus-infection-illustration.webp?t=1768921542" type="image/jpeg" medium="image" fileSize="929370">
        <media:title type="plain">Sinus anatomy with virus cells</media:title>
      </media:content>
    </item>
    <item>
      <title>NIH launches new center to replace animal testing with organoids</title>
      <description>
        <![CDATA[About five months after the U.S. FDA disclosed its roadmap to move away from animal testing in favor of new approaches for biopharma drug development, the U.S. National Institutes of Health (NIH) said it is awarding $87 million in contracts over three years to launch the Standardized Organoid Modeling Center.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724668</guid>
      <pubDate>Fri, 26 Sep 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724668-nih-launches-new-center-to-replace-animal-testing-with-organoids</link>
    </item>
    <item>
      <title>South Korea forms new organoid consortium for nonanimal testing</title>
      <description>
        <![CDATA[South Korea’s Ministry of Food and Drug Safety (MFDS) launched a new industry-academia-research consortium to support the nation’s organoid industry, expected to grow in light of the U.S. FDA’s shift away from animal testing in the development of novel drugs.]]>
      </description>
      <guid>http://www.bioworld.com/articles/723658</guid>
      <pubDate>Tue, 26 Aug 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723658-south-korea-forms-new-organoid-consortium-for-nonanimal-testing</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2025/Korea-organoid-hero-8-21.webp?t=1755810389" type="image/jpeg" medium="image" fileSize="854198">
        <media:title type="plain">K-Organoid Consortium group photo</media:title>
        <media:description type="plain">K-Organoid Consortium launching ceremony in Seoul, South Korea Aug. 13</media:description>
      </media:content>
    </item>
    <item>
      <title>South Korea forms new organoid consortium for nonanimal testing</title>
      <description>
        <![CDATA[South Korea’s Ministry of Food and Drug Safety (MFDS) launched a new industry-academia-research consortium to support the nation’s organoid industry, expected to grow in light of the U.S. FDA’s shift away from animal testing in the development of novel drugs.]]>
      </description>
      <guid>http://www.bioworld.com/articles/723543</guid>
      <pubDate>Thu, 21 Aug 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723543-south-korea-forms-new-organoid-consortium-for-nonanimal-testing</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2025/Korea-organoid-hero-8-21.webp?t=1755810389" type="image/jpeg" medium="image" fileSize="854198">
        <media:title type="plain">K-Organoid Consortium group photo</media:title>
        <media:description type="plain">K-Organoid Consortium launching ceremony in Seoul, South Korea Aug. 13</media:description>
      </media:content>
    </item>
    <item>
      <title>South Korea forms new organoid consortium for nonanimal testing</title>
      <description>
        <![CDATA[South Korea’s Ministry of Food and Drug Safety (MFDS) launched a new industry-academia-research consortium to support the nation’s organoid industry, expected to grow in light of the U.S. FDA’s shift away from animal testing in the development of novel drugs.]]>
      </description>
      <guid>http://www.bioworld.com/articles/723276</guid>
      <pubDate>Thu, 21 Aug 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723276-south-korea-forms-new-organoid-consortium-for-nonanimal-testing</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2025/Korea-organoid-hero-8-21.webp?t=1755810389" type="image/jpeg" medium="image" fileSize="854198">
        <media:title type="plain">K-Organoid Consortium group photo</media:title>
        <media:description type="plain">K-Organoid Consortium launching ceremony in Seoul, South Korea Aug. 13</media:description>
      </media:content>
    </item>
    <item>
      <title>Technique for aging brain organoids makes better Alzheimer’s model</title>
      <description>
        <![CDATA[A new method for accelerating the maturation of neuronal cell models and brain organoids is poised to make it possible to track the etiology of neurodegenerative diseases that develop over decades.  The non-invasive technique uses graphene to convert light into electrical cues that prompt neurons to connect and communicate in vitro.]]>
      </description>
      <guid>http://www.bioworld.com/articles/723515</guid>
      <pubDate>Thu, 21 Aug 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723515-technique-for-aging-brain-organoids-makes-better-alzheimers-model</link>
    </item>
    <item>
      <title>FDA shift from animal testing fuels organoid, organ-on-chip demand</title>
      <description>
        <![CDATA[The U.S. FDA’s decision to phase out animal testing for INDs is driving a new market of alternative, nonanimal testing technologies like organoids and organs-on-a-chip, speakers at Bio Korea 2025 said.]]>
      </description>
      <guid>http://www.bioworld.com/articles/720229</guid>
      <pubDate>Wed, 14 May 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/720229-fda-shift-from-animal-testing-fuels-organoid-organ-on-chip-demand</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Koreabio-Humanase-KOH-Sungho-9may25.webp?t=1746820611" type="image/jpeg" medium="image" fileSize="200403">
        <media:title type="plain">Koreabio Humanase KOH Sungho</media:title>
        <media:description type="plain">Humanase CEO Koh Sung-ho presented on organ-on-a-chip technology at Bio Korea 2025 May 9 in Seoul, South Korea.</media:description>
      </media:content>
    </item>
    <item>
      <title>Organoids plus gene editing bring insights into pediatric metabolic disease</title>
      <description>
        <![CDATA[“I’m a pediatrician in metabolic diseases, and every day in my clinical work I’m confronted with our lack in effective therapies for our patients.” That was the sobering introduction by Sabine Fuchs in her talk at the 2025 Congress of the European Association for the Study of the Liver in Amsterdam this week. The nature of metabolic diseases makes it difficult to develop treatments for them. “There are over 1,500 diseases known by now, and it is just very difficult to develop therapies for each and every individual rare disease.”]]>
      </description>
      <guid>http://www.bioworld.com/articles/720006</guid>
      <pubDate>Thu, 08 May 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/720006-organoids-plus-gene-editing-bring-insights-into-pediatric-metabolic-disease</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Research-and-science/DNA-and-silhouette.webp?t=1683924114" type="image/jpeg" medium="image" fileSize="452579">
        <media:title type="plain">DNA and silhouette</media:title>
      </media:content>
    </item>
    <item>
      <title>More than 100M cells included in the human cell atlas</title>
      <description>
        <![CDATA[An international consortium of thousands of scientists is creating the Human Cell Atlas, a three-dimensional map of all the cells in the body. The goal is to understand all the cells that make up human tissues, organs and systems, which will enable multiple medical applications. This collection of cell maps is openly available for navigation at single-cell resolution, identified through omics analyses that reveal the tridimensional distribution of each cell.]]>
      </description>
      <guid>http://www.bioworld.com/articles/714904</guid>
      <pubDate>Tue, 26 Nov 2024 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/714904-more-than-100m-cells-included-in-the-human-cell-atlas</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-source/Embryonic-skeletal-development-hero-11-21.webp?t=1732207101" type="image/jpeg" medium="image" fileSize="471182">
        <media:title type="plain">D-rendered image showing atlas of human embryonic skeletal development</media:title>
        <media:description type="plain">Atlas of human embryonic skeletal development. A 3D-rendered image showing where the skeleton has cartilage (purple), which acts as a ‘scaffold’ before bone (purple) is formed in the majority of the skeleton. It also shows the cellular make-up in a developing cranium, where the top of the skull does not have any cartilage (blue), showing it forms bone uniquely without needing cartilage preceding. Credit: A. Chédotal &amp;amp; R. Blain, Institut de la Vision, Paris &amp;amp; MeLiS/UCBL/ HCL, Lyon.</media:description>
      </media:content>
    </item>
    <item>
      <title>More than 100M cells included in the human cell atlas</title>
      <description>
        <![CDATA[An international consortium of thousands of scientists is creating the Human Cell Atlas, a three-dimensional map of all the cells in the body. The goal is to understand all the cells that make up human tissues, organs and systems, which will enable multiple medical applications. This collection of cell maps is openly available for navigation at single-cell resolution, identified through omics analyses that reveal the tridimensional distribution of each cell.]]>
      </description>
      <guid>http://www.bioworld.com/articles/714679</guid>
      <pubDate>Thu, 21 Nov 2024 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/714679-more-than-100m-cells-included-in-the-human-cell-atlas</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-source/Embryonic-skeletal-development-hero-11-21.webp?t=1732207101" type="image/jpeg" medium="image" fileSize="471182">
        <media:title type="plain">D-rendered image showing atlas of human embryonic skeletal development</media:title>
        <media:description type="plain">Atlas of human embryonic skeletal development. A 3D-rendered image showing where the skeleton has cartilage (purple), which acts as a ‘scaffold’ before bone (purple) is formed in the majority of the skeleton. It also shows the cellular make-up in a developing cranium, where the top of the skull does not have any cartilage (blue), showing it forms bone uniquely without needing cartilage preceding. Credit: A. Chédotal &amp;amp; R. Blain, Institut de la Vision, Paris &amp;amp; MeLiS/UCBL/ HCL, Lyon.</media:description>
      </media:content>
    </item>
    <item>
      <title>(Modest) funding increases bring endometriosis discovery impetus</title>
      <description>
        <![CDATA[After decades of being woefully under-diagnosed and all but ignored by the biotech and pharma industry, recent advances in understanding its complex etiology could be opening the way to new treatments for endometriosis. Impetus is coming from (modest) increases in funding for basic research, such as the Biden administration’s $200 million for women’s health research and NIH grants under an ‘Advancing cures and therapies and ending endometriosis diagnostic delays’ call announced in March of this year.]]>
      </description>
      <guid>http://www.bioworld.com/articles/711402</guid>
      <pubDate>Fri, 09 Aug 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/711402-modest-funding-increases-bring-endometriosis-discovery-impetus</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Sexual-health/Gynecology-Endometriosis.webp?t=1677686044" type="image/png" medium="image" fileSize="538269">
        <media:title type="plain">Illustration of ovaries and uterus with endometriosis</media:title>
      </media:content>
    </item>
    <item>
      <title>Astellas and Osaka University collaborate on cartilage organoid cell therapy for intervertebral disc degeneration</title>
      <description>
        <![CDATA[Astellas Pharma Inc.’s subsidiaries Astellas Institute for Regenerative Medicine (AIRM) and Universal Cells Inc. have entered into a research collaboration with Osaka University to develop a pluripotent stem cell-derived cartilage organoid cell therapy for the treatment of intervertebral disc degenerative disease.]]>
      </description>
      <guid>http://www.bioworld.com/articles/710684</guid>
      <pubDate>Mon, 22 Jul 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/710684-astellas-and-osaka-university-collaborate-on-cartilage-organoid-cell-therapy-for-intervertebral-disc-degeneration</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Musculoskeletal/spine-orthopedic-back.webp?t=1589217875" type="image/png" medium="image" fileSize="468880">
        <media:title type="plain">3D model, X-rays of spine</media:title>
      </media:content>
    </item>
    <item>
      <title>Fibrobiologics’ artificial thymus organoid restores immune function in SCID mouse model</title>
      <description>
        <![CDATA[Fibrobiologics Inc. has announced the development of a novel artificial thymus organoid that can restore immune function in a severe combined immunodeficiency (SCID) mouse model.]]>
      </description>
      <guid>http://www.bioworld.com/articles/709870</guid>
      <pubDate>Wed, 26 Jun 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/709870-fibrobiologics-artificial-thymus-organoid-restores-immune-function-in-scid-mouse-model</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Immune/Thymus-organ-immune.webp?t=1696258546" type="image/jpeg" medium="image" fileSize="105048">
        <media:title type="plain">Illustration of thymus in relation to lungs and thyroid</media:title>
      </media:content>
    </item>
    <item>
      <title>3D organoids arising from amniotic fluid cells may be a potent prenatal tool</title>
      <description>
        <![CDATA[Organoids are 3D models created from human stem cells and resemble fetal tissues. In an article published in <em>Nature Medicine</em> on March 4, 2024, researchers from University College London provided details on the possibility of generating organoids from epithelial cells collected from amniotic fluid without terminating the pregnancy.]]>
      </description>
      <guid>http://www.bioworld.com/articles/706475</guid>
      <pubDate>Fri, 08 Mar 2024 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/706475-3d-organoids-arising-from-amniotic-fluid-cells-may-be-a-potent-prenatal-tool</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/organoids-petri-dish.webp?t=1709922088" type="image/jpeg" medium="image" fileSize="115495">
        <media:title type="plain">3D illustration of organoid models in a petri dish</media:title>
        <media:description type="plain">3D illustration of organoid models in a petri dish</media:description>
      </media:content>
    </item>
    <item>
      <title>3D organoids arising from amniotic fluid cells may be a potent prenatal tool</title>
      <description>
        <![CDATA[Organoids are 3D models created from human stem cells and resemble fetal tissues. In an article published in <em>Nature Medicine</em> on March 4, 2024, researchers from University College London provided details on the possibility of generating organoids from epithelial cells collected from amniotic fluid without terminating the pregnancy.]]>
      </description>
      <guid>http://www.bioworld.com/articles/706268</guid>
      <pubDate>Tue, 05 Mar 2024 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/706268-3d-organoids-arising-from-amniotic-fluid-cells-may-be-a-potent-prenatal-tool</link>
    </item>
    <item>
      <title>Stem Pharm and Verge Genomics collaborate on disease model to validate Parkinson’s targets</title>
      <description>
        <![CDATA[Stem Pharm Inc. and Verge Genomics (Verge Analytics Inc.) have established a collaboration to develop a disease model to validate novel targets identified by Verge for Parkinson’s disease.]]>
      </description>
      <guid>http://www.bioworld.com/articles/701725</guid>
      <pubDate>Wed, 11 Oct 2023 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/701725-stem-pharm-and-verge-genomics-collaborate-on-disease-model-to-validate-parkinsons-targets</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Neurology/Parkinsons-neurons-Lewy-bodies.webp?t=1642020118" type="image/png" medium="image" fileSize="441475">
        <media:title type="plain">Parkinson's disease illustration showing neurons containing alpha-synuclein</media:title>
      </media:content>
    </item>
    <item>
      <title>Intron demonstrates inhibition of tumorigenesis using P18-BE3CRC in colorectal cancer organoid model</title>
      <description>
        <![CDATA[Intron Biotechnology Inc. has demonstrated the effectiveness of P18-BE3CRC using a cancer organoid model. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/695740</guid>
      <pubDate>Tue, 04 Apr 2023 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/695740-intron-demonstrates-inhibition-of-tumorigenesis-using-p18-be3crc-in-colorectal-cancer-organoid-model</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Cancer/colon-cancer-cell.webp?t=1588881323" type="image/png" medium="image" fileSize="447411">
        <media:title type="plain">Colon cancer illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Collplant, Tel Aviv University and Sheba Medical Center collaborate on gut-on-a-chip tissue model </title>
      <description>
        <![CDATA[Collplant Biotechnologies Ltd. and Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University and Sheba Medical Center, have entered into a license and research agreement to codevelop a gut-on-a-chip tissue model for drug discovery and high-throughput screening of drugs.]]>
      </description>
      <guid>http://www.bioworld.com/articles/691638</guid>
      <pubDate>Wed, 16 Nov 2022 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/691638-collplant-tel-aviv-university-and-sheba-medical-center-collaborate-on-gut-on-a-chip-tissue-model</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Gastrointestinal/Gastrointestinal-microbiome.webp?t=1589217172" type="image/png" medium="image" fileSize="442923">
        <media:title type="plain">Intestine</media:title>
      </media:content>
    </item>
    <item>
      <title>Unravel Biosciences and Spanios partner to discover therapeutic targets for rare cancers</title>
      <description>
        <![CDATA[Unravel Biosciences Inc. has entered into a partnership with Spanios to discover therapeutic targets for rare cancers.]]>
      </description>
      <guid>http://www.bioworld.com/articles/691448</guid>
      <pubDate>Thu, 10 Nov 2022 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/691448-unravel-biosciences-and-spanios-partner-to-discover-therapeutic-targets-for-rare-cancers</link>
    </item>
    <item>
      <title>Transplanted human cortical organoids integrate anatomically and functionally into the rodent brain</title>
      <description>
        <![CDATA[Self-organizing organoids resembling specific regions of the nervous system, including human cortical organoids (hCO), can be generated and used as disease models. However, the application of hCOs is precluded by several limitations, including the lack of integration into in vivo circuits that generate behavioral outputs. To overcome these issues, transplantation of hCOs into intact living brains has been proposed.]]>
      </description>
      <guid>http://www.bioworld.com/articles/691205</guid>
      <pubDate>Thu, 03 Nov 2022 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/691205-transplanted-human-cortical-organoids-integrate-anatomically-and-functionally-into-the-rodent-brain</link>
    </item>
    <item>
      <title>Sengine Precision seeks to identify novel therapeutic targets in progressive ALK+ NSCLC</title>
      <description>
        <![CDATA[Sengine Precision Medicine Inc. is conducting a study utilizing its high-throughput patient-derived organoid drug screening technology to identify novel therapeutic targets in progressive anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC).]]>
      </description>
      <guid>http://www.bioworld.com/articles/690081</guid>
      <pubDate>Thu, 29 Sep 2022 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/690081-sengine-precision-seeks-to-identify-novel-therapeutic-targets-in-progressive-alk-nsclc</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Cancer/Lung-cancer-3d-illo.webp?t=1745257422" type="image/jpeg" medium="image" fileSize="363200">
        <media:title type="plain">Lung cancer illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Emulate launches new AAV transduction application for Liver-Chip</title>
      <description>
        <![CDATA[Emulate Inc. has launched a new adeno-associated virus (AAV) transduction application for the Liver-Chip that enables gene therapy researchers to test the delivery efficiency and safety of AAV vectors in a validated, human-relevant model of the liver and get results in weeks.]]>
      </description>
      <guid>http://www.bioworld.com/articles/689807</guid>
      <pubDate>Tue, 20 Sep 2022 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/689807-emulate-launches-new-aav-transduction-application-for-liver-chip</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2020/Sep-2020/Science-liver-organoid-9-9.webp?t=1599675172" type="image/png" medium="image" fileSize="644310">
        <media:title type="plain">Liver organoid</media:title>
        <media:description type="plain">Color-enhanced confocal microscope image of a liver organoid.
Credit: Cincinnati Children’s
</media:description>
      </media:content>
    </item>
    <item>
      <title>Sengine nearly quadruples funding with $15M series A to advance organoid-based testing</title>
      <description>
        <![CDATA[Sengine Precision Medicine Inc. boosted its total fundraising to $19 million with the recent closing of a $10 million series A2 led by the Washington Research Foundation with support from Alethea Fulcrum Fund, Vincere Capital Biotech LLC, Bangarang Group and others. The A2 follows on an earlier $5 million raised in the original series A. Sengine’s Paris Test predicts drug responses using a patient’s cancer cells to grow a tumor organoid that replicates the functionality and genomic characteristics of the original tumor, enabling hyper-personalization of cancer treatment.]]>
      </description>
      <guid>http://www.bioworld.com/articles/521414</guid>
      <pubDate>Mon, 08 Aug 2022 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/521414-sengine-nearly-quadruples-funding-with-15m-series-a-to-advance-organoid-based-testing</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/3D-dollar-sign.webp?t=1624487200" type="image/png" medium="image" fileSize="316216">
        <media:title type="plain">3D dollar sign</media:title>
      </media:content>
    </item>
    <item>
      <title>Xilis lands $19M series A extension for microorganosphere platform</title>
      <description>
        <![CDATA[Xilis Inc. added $19 million to its series A financing round, bringing the total amount raised to over $89 million. FPV Ventures led the extension, with participation from Alexandria Venture Investments and EQT Life Sciences, Mubadala Capital Management, Pear Ventures, GV, the Duke Angel Network, Catalio Capital Management, Two Sigma Ventures, Felicis Ventures and Alix Ventures.]]>
      </description>
      <guid>http://www.bioworld.com/articles/520717</guid>
      <pubDate>Thu, 14 Jul 2022 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/520717-xilis-lands-19m-series-a-extension-for-microorganosphere-platform</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/Dollar-sign-in-light-bulb-on-yellow-background.webp?t=1637008317" type="image/png" medium="image" fileSize="77494">
        <media:title type="plain">Dollar sign in light bulb on yellow background</media:title>
      </media:content>
    </item>
    <item>
      <title>Three components enable 3D kidney tissue from mouse embryonic stem cells</title>
      <description>
        <![CDATA[Japanese researchers have created complex 3D kidney organoids that could lead the way to better kidney research and even artificial kidneys for human transplant.]]>
      </description>
      <guid>http://www.bioworld.com/articles/515866</guid>
      <pubDate>Tue, 08 Feb 2022 11:05:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/515866-three-components-enable-3d-kidney-tissue-from-mouse-embryonic-stem-cells</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Nephrology/Kidneys3.webp?t=1637092659" type="image/png" medium="image" fileSize="437796">
        <media:title type="plain">Kidneys</media:title>
      </media:content>
    </item>
    <item>
      <title>Human heart organoids provide unmatched insight into cardiac disease and dysfunction</title>
      <description>
        <![CDATA[Two teams of researchers have developed miniature models of the human heart that beat and function like the full-size organ. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/498885</guid>
      <pubDate>Tue, 13 Oct 2020 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/498885-human-heart-organoids-provide-unmatched-insight-into-cardiac-disease-and-dysfunction</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2020/10-12-MUSC-heart-attack-in-a-dish.webp?t=1602541727" type="image/png" medium="image" fileSize="656171">
        <media:title type="plain">Diagram comparing healthy heart organoid to post-heart attack organoid</media:title>
        <media:description type="plain">A team from MUSC developed a “heart attack in a dish” model. Low-oxygen cell culture conditions combined with human heart organoids recreate tissue-level features of a post-heart attack heart. Image courtesy of Dylan Richards, MUSC.</media:description>
      </media:content>
    </item>
    <item>
      <title>Human heart organoids provide unmatched insight into cardiac disease and dysfunction</title>
      <description>
        <![CDATA[Two teams of researchers have developed miniature models of the human heart that beat and function like the full-size organ. The team from Michigan State University (MSU) and Washington University in St. Louis developed a human heart organoid (hHO) that recapitulates embryonic heart development, providing an unmatched view into congenital heart defects. The organoid created by the researchers at the Medical University of South Carolina (MUSC) and Clemson University mimics the tissue dysfunction that occurs following a heart attack.]]>
      </description>
      <guid>http://www.bioworld.com/articles/498842</guid>
      <pubDate>Mon, 12 Oct 2020 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/498842-human-heart-organoids-provide-unmatched-insight-into-cardiac-disease-and-dysfunction</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2020/10-12-MUSC-heart-attack-in-a-dish.webp?t=1602541727" type="image/png" medium="image" fileSize="656171">
        <media:title type="plain">Diagram comparing healthy heart organoid to post-heart attack organoid</media:title>
        <media:description type="plain">A team from MUSC developed a “heart attack in a dish” model. Low-oxygen cell culture conditions combined with human heart organoids recreate tissue-level features of a post-heart attack heart. Image courtesy of Dylan Richards, MUSC.</media:description>
      </media:content>
    </item>
    <item>
      <title>Down syndrome organoids give insights into Alzheimer’s disease</title>
      <description>
        <![CDATA[LONDON – New human brain organoids that precisely model the three hallmarks of Alzheimer’s disease – amyloid plaque-like lesions, progressive neuronal death and abnormal accumulations of tau – are now ready to be developed for use in high-throughput drug screening.]]>
      </description>
      <guid>http://www.bioworld.com/articles/455823</guid>
      <pubDate>Fri, 17 Jul 2020 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/455823-down-syndrome-organoids-give-insights-into-alzheimers-disease</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Neurology/Brain-with-puzzle-piece-removed.webp?t=1595012724" type="image/png" medium="image" fileSize="452654">
        <media:title type="plain">Brain with puzzle piece removed</media:title>
      </media:content>
    </item>
    <item>
      <title>‘Hope, hype and hubris’ of brain organoids on display at stem cell meeting</title>
      <description>
        <![CDATA[Technical challenges at the annual meeting of the International Society for Stem Cell Research (ISSCR) meeting led to at least one lively exchange of stem cell jokes in the chat box as the audience waited for talks to resume, including stem cell parental advice: “You can be anything you want when you grow up!”]]>
      </description>
      <guid>http://www.bioworld.com/articles/436091</guid>
      <pubDate>Fri, 26 Jun 2020 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/436091-hope-hype-and-hubris-of-brain-organoids-on-display-at-stem-cell-meeting</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2020/Jun-2020/Stem-cell-derived-cerebral-organoid-6-26.webp?t=1593438876" type="image/png" medium="image" fileSize="448286">
        <media:title type="plain">Stem cell-derived cerebral organoid</media:title>
        <media:description type="plain">Stem cell-derived cerebral organoid. Credit: Elizabeth Di Lullo</media:description>
      </media:content>
    </item>
  </channel>
</rss>
